Tousignant Jennifer
SEC insider (Form 3/4/5 filer). CIK 0002010978. Chief Legal Officer at Viridian Therapeutics, Inc.\DE (VRDN). 11 reported Form 4/5 transactions since Sep 2024; latest on Aug 19, 2026. Located in WALTHAM, MA.
Companies Tousignant Jennifer has filed insider reports for
- Viridian Therapeutics, Inc.\DE (VRDN): Officer, Chief Legal Officer
Tousignant Jennifer
CIK: 0002010978
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viridian Therapeutics, Inc.\DE
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 19, 2026VRDN
Viridian Therapeutics, Inc.\DE
SaleDirect10K shares at avg. $24.50$245K - Aug 19, 2026VRDN
Viridian Therapeutics, Inc.\DE
SaleDirect4.2K shares at avg. $24.50$103K - Aug 19, 2026VRDN
Viridian Therapeutics, Inc.\DE
ExerciseDirect10K shares at avg. $14.41$144K - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
Tax PaymentDirect1.7K shares at avg. $30.19$51K - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
ExerciseDirect5.2K shares- - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
Tax PaymentDirect1.7K shares at avg. $29.32$51K - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
119.3K shares- - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectRestricted Stock Units
23.9K shares- - Dec 31, 2025VRDN
Viridian Therapeutics, Inc.\DE
SaleDirect2.3K shares at avg. $31.16$71K - Mar 3, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
124.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 19, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sale | 10,000 | $24.50 | $245,000 | Direct |
| Aug 19, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sale | 4,212 | $24.50 | $103,194 | Direct |
| Aug 19, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Exercise | 10,000 | $14.41 | $144,100 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Tax Payment | 1,675 | $30.19 | $50,568 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Exercise | 5,169 | - | $0 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Tax Payment | 1,724 | $29.32 | $50,548 | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 119,300 | - | - | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Restricted Stock Units | 23,850 | - | - | Direct |
| Dec 31, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Sale | 2,272 | $31.16 | $70,796 | Direct |
| Mar 3, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 124,072 | - | - | Direct |
1-10 of 11 transactions